Lymphoma, B-Cell, Marginal Zone
"Lymphoma, B-Cell, Marginal Zone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.
| Descriptor ID |
D018442
|
| MeSH Number(s) |
C04.557.386.480.150.570 C15.604.515.569.480.150.570 C20.683.515.761.480.150.570
|
| Concept/Terms |
Lymphoma, B-Cell, Marginal Zone- Lymphoma, B-Cell, Marginal Zone
- MALT Lymphoma
- Lymphoma, MALT
- Lymphomas, MALT
- MALT Lymphomas
- Lymphoma of Mucosa-Associated Lymphoid Tissue
- Lymphoma of Mucosa Associated Lymphoid Tissue
- Mucosa-Associated Lymphoid Tissue Lymphoma
- Mucosa Associated Lymphoid Tissue Lymphoma
- Lymphoma, Mucosa-Associated Lymphoid Tissue
- Lymphoma, Mucosa Associated Lymphoid Tissue
- Marginal Zone B-Cell Lymphoma
- Marginal Zone B Cell Lymphoma
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, B-Cell, Marginal Zone".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, B-Cell [C04.557.386.480.150]
- Lymphoma, B-Cell, Marginal Zone [C04.557.386.480.150.570]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, B-Cell [C15.604.515.569.480.150]
- Lymphoma, B-Cell, Marginal Zone [C15.604.515.569.480.150.570]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, B-Cell [C20.683.515.761.480.150]
- Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, B-Cell, Marginal Zone".
This graph shows the total number of publications written about "Lymphoma, B-Cell, Marginal Zone" by people in this website by year, and whether "Lymphoma, B-Cell, Marginal Zone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, B-Cell, Marginal Zone" by people in Profiles.
-
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study. Blood Adv. 2023 11 28; 7(22):6839-6843.
-
Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood Adv. 2023 01 10; 7(1):88-91.
-
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study. J Hematol Oncol. 2022 07 16; 15(1):96.
-
Hematologic Malignancies Discovered on Investigation of Breast Abnormalities. South Med J. 2017 10; 110(10):614-620.
-
A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease. Pediatr Blood Cancer. 2015 May; 62(5):905-8.
-
Ocular adnexal MALTomas: case series of patients treated with primary radiation. Clin Adv Hematol Oncol. 2013 Apr; 11(4):209-14.
-
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):467-74.